3 Biotech Stocks Under $15 Worth a Second Look in 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Related Keywords

John Jacobs ,Stanley Erck ,Zealand Pharma ,Drug Administration ,Anavex Life Sciences ,Harmony Biosciences ,United Therapeutics ,Disease Assessment Scale ,